Addonizio L J, Rose E A
Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York.
J Pediatr. 1987 Dec;111(6 Pt 2):1034-8. doi: 10.1016/s0022-3476(87)80052-5.
Between June 1984 and October 1986, we evaluated 22 children for possible cardiac transplantation at Columbia-Presbyterian Medical Center. Four children died awaiting donor organs. Fifteen children received transplants; eight had cardiomyopathy, and seven had congenital heart disease. One child received a heterotopic transplant because of extremely high pulmonary vascular resistance. Immunosuppressive therapy consisted of 4 to 40 mg/kg/d cyclosporine and 0.2 to 0.5 mg/kg/d prednisone. Rejection was detected by the presence of myocyte necrosis in surveillance endomyocardial biopsy specimens. There were one intraoperative and three early deaths, two from infection and one rejection. The 11 survivors are observed from a few weeks to more than 2 years after transplantation, and all are in excellent clinical health and participate in age-appropriate activities. These data corroborate the experience of other institutions that cardiac transplantation is a valid treatment in children.
1984年6月至1986年10月期间,我们在哥伦比亚长老会医学中心对22名可能适合心脏移植的儿童进行了评估。4名儿童在等待供体器官时死亡。15名儿童接受了移植;8名患有心肌病,7名患有先天性心脏病。1名儿童因肺血管阻力极高接受了异位移植。免疫抑制治疗包括每天每千克体重4至40毫克环孢素和每天每千克体重0.2至0.5毫克泼尼松。通过监测心内膜活检标本中是否存在心肌细胞坏死来检测排斥反应。有1例术中死亡和3例早期死亡,2例死于感染,1例死于排斥反应。11名幸存者在移植后从几周观察到两年多,所有幸存者临床健康状况良好,能参加适合其年龄的活动。这些数据证实了其他机构的经验,即心脏移植对儿童来说是一种有效的治疗方法。